HPTN 083 is a study being done to evaluate the efficacy of the long-acting injectable agent, cabotegravir (CAB LA), for...
The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...
This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
Efavirenz (EFV) is an anti-HIV medicine that is commonly used to treat HIV infection in adults and children older than 3 years...
HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...
